Loading...
Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts
BACKGROUND: Intestinal fibrosis is a serious complication of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. There is no specific treatment for intestinal fibrosis. Studies have indicated that peroxisome proliferator-activated receptor- γ (PPAR-γ) agonists have anti-fib...
Na minha lista:
| Udgivet i: | BMC Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463383/ https://ncbi.nlm.nih.gov/pubmed/28592228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-017-0627-4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|